A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.
about
Chinese herbal medicine Huangqi type formulations for nephrotic syndromeImmunosuppressive treatment for focal segmental glomerulosclerosis in adultsTreatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gelRecent Advances in Treatments of Primary Focal Segmental Glomerulosclerosis in ChildrenTreatment Strategies of Adult Primary Focal Segmental Glomerulosclerosis: A Systematic Review Focusing on the Last Two DecadesCalcineurin Inhibitors in the Treatment of Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis of the LiteratureClinical trials treating focal segmental glomerulosclerosis should measure patient quality of lifeMYO1E mutations and childhood familial focal segmental glomerulosclerosis.The impact of sex in primary glomerulonephritis.Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group.Idiopathic collapsing focal segmental glomerulosclerosis in an 81-year-old Japanese woman: a case report and review of the literature.Angiotensin-converting enzyme gene polymophism in adult primary focal segmental glomerulosclerosis.Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysisNovel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study designRefractory focal segmental glomerulosclerosis in the adult: complete and sustained remissions of two episodes of nephrotic syndrome after a single dose of rituximabSignificance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trialImmunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome.Early change in proteinuria as a surrogate outcome in kidney disease progression: a systematic review of previous analyses and creation of a patient-level pooled dataset.The need for improved uptake of the KDIGO glomerulonephritis guidelines into clinical practice in Canada: a survey of nephrologists.Emerging drugs for renal failure.Therapeutic approach to FSGS in children.Evidence-based guide to slowing the progression of early renal insufficiency.A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis.Focal segmental glomerulosclerosis: molecular genetics and targeted therapiesAssociation of Relapse with Renal Outcomes under the Current Therapy Regimen for IgA Nephropathy: A Multi-Center Study.Clinical trial of focal segmental glomerulosclerosis in children and young adults.Long-Term Outcomes in Children with Steroid-Resistant Nephrotic Syndrome Treated with Calcineurin Inhibitors.Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic SyndromeRenal function and proteinuria after successful immunosuppressive therapies in patients with FSGS.Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGSTacrolimus in the treatment of idiopathic nephrotic syndrome.Familial collapsing focal segmental glomerulosclerosis.Adrenocorticotropic hormone analog use for podocytopathiesClinicopathological correlation and treatment response of primary focal segmental glomerulosclerosis in adults and adolescents.Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosisCyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie.Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.Pathogenesis and therapy of focal segmental glomerulosclerosis: an update.Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients.Educational paper: the podocytopathies.
P2860
Q24202262-42035DDB-DCBC-45A7-B989-826DED56A08CQ24242266-E1E44E75-E29F-4C87-A27A-A330801D9FB9Q24632899-70A2140E-CA1A-4909-B46C-B27051880F77Q26747770-B9A6595E-BC42-49AA-BD46-376BED2B2E0CQ26752836-3B4FDFB6-3279-443A-8974-ECDF7146E786Q30235177-9214311D-0AB4-483B-9055-81DCE050F8B4Q30427819-2E700B0D-87FD-435D-8BC0-D45A4E57CAD9Q30541167-FA518D72-CC7E-4891-A551-99049F23725DQ33313682-A3FBCC32-42BE-47D6-82A4-258CCBA1F1D0Q33527568-CA3130F6-39CF-4ADF-B700-B3EF7D936B5AQ33628328-BAB8FE79-9AA1-4734-9296-90A5C51B933FQ33688313-EFE0A8D6-F3BB-4A79-B967-7A1C0820469AQ33805412-A1B42289-BF31-44BD-A73D-67F058986E59Q33817568-9D806389-4726-4A9E-AB34-7E8BC481944AQ34130591-68BDEF5D-C6C4-40FD-B0E5-D93356ED1493Q34324240-CDF6AE6C-B83D-4354-91AD-A8E567C87684Q34405386-957F085F-4BB1-4FE9-80ED-E5B329853CEFQ35025425-9EC05474-5C5B-4884-BC81-ACEB92936C0FQ35310613-FA4404D9-736D-448E-9BFE-EA222D4831EEQ35602657-14206BCA-3D5E-425A-B13A-10193E2F6B79Q35614311-EFC76EC8-8067-41C0-B59B-0CD8B3941EFCQ35641499-3EF5BF8A-FF6F-4532-AAF3-BFBAF2330E3CQ35669295-4F256602-6E43-4F17-ABD2-C7E31F9F2A1FQ35686453-7D9057B1-7F0E-415E-936C-09B279DD37F9Q35775659-626A22E6-126F-48CC-8407-A03232C1653EQ35837532-2C32F93E-C432-4C1E-8E29-C62E8B89DFAAQ36322955-F770045E-5BDC-419C-9DB4-E54A5AC961D2Q36543103-C7A42EFE-8DE4-4460-9399-86399CDD4EB5Q36583388-98317A2A-A421-4FC7-8114-8064249A92A2Q36686985-40BDF119-3D1E-4D99-BFDE-B0A02CDEE763Q36861628-75C66F72-241D-4C78-B688-21368D41E7FCQ36944855-86B186BF-A36D-4480-B3E0-E36DB8F2A0F2Q37070458-C3667BC5-28AE-43C1-9079-1E05A346DE06Q37241092-67FFB835-2B1E-42D6-BFBE-7B4227654739Q37297636-82B28723-38C7-4DB7-852E-C052891E712EQ37315097-0F2D54AA-5FEF-47A5-A577-8676D7C28E94Q37359035-B29C56E5-849E-4567-9FCA-AD0CC0653A9BQ37812564-F93BDCBC-CB76-4F49-A3DE-9220ECDE7EFDQ37928188-84B18249-9F60-44DC-BE46-71F44E24A11AQ37975102-4DC5C25F-E892-4D66-9F2F-28AFF12C4212
P2860
A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A randomized trial of cyclospo ...... ephrotic Syndrome Study Group.
@ast
A randomized trial of cyclospo ...... ephrotic Syndrome Study Group.
@en
type
label
A randomized trial of cyclospo ...... ephrotic Syndrome Study Group.
@ast
A randomized trial of cyclospo ...... ephrotic Syndrome Study Group.
@en
prefLabel
A randomized trial of cyclospo ...... ephrotic Syndrome Study Group.
@ast
A randomized trial of cyclospo ...... ephrotic Syndrome Study Group.
@en
P2093
P1433
P1476
A randomized trial of cyclospo ...... Nephrotic Syndrome Study Group
@en
P2093
Cattran DC
Hunsicker LG
Maxwell DR
P304
P356
10.1046/J.1523-1755.1999.00778.X
P407
P50
P577
1999-12-01T00:00:00Z
P5875
P6179
1034734140